» Articles » PMID: 28422821

How the Cognitive Reserve Interacts with β-amyloid Deposition in Mitigating FDG Metabolism: An Observational Study

Overview
Specialty General Medicine
Date 2017 Apr 20
PMID 28422821
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

This observational study had the aim to assess the interaction between cognitive reserve (CR) and cerebrospinal fluid β-amyloid1-42 (Aβ1-42) in modulating brain [18F]fluorodeoxyglucose positron emission tomography (FDG-PET) metabolism in patients with moderate Alzheimer disease (AD).Twenty-seven patients with probable AD and 25 neurological normal subjects (NNS) entered the study. All participants had an FDG-PET scan, and AD patients also received a lumbar puncture to measure Aβ1-42, 181p-tau, and Tau concentrations. Based on years of formal education, AD patients were classified as highly educated-AD (years of formal education >5) or less educated-AD (years of formal education <5). By using a voxel-wise approach, we first investigated differences in the cerebral glucose uptake between AD and NNS, then we assessed the interaction between level of education (a proxy of CR) and cerebrospinal fluid biomarkers on FDG-PET metabolism in the patient groups.Significantly lower glucose uptake was observed in the posterior cingulate gyrus, in the precuneus, in the inferior and medial temporal gyrus, and in the inferior parietal lobule of AD patients compared with NNS. A significant interaction was found between CR and Aβ1-42 values on brain metabolism in the inferior and medial temporal gyrus bilaterally.The AD patients with higher CR level and marked signs of neuropathology showed glucose hypometabolism in regions typically targeted by AD pathology. This finding supports the hypothesis that CR partially compensates for the effect of Aβ plaques on cognitive impairment, helps in patients' clinical staging, and opens new possibilities for the development of nonpharmacological interventions.

Citing Articles

Dynamic neurocognitive adaptation in aging: Development and validation of a new scale.

Cieri F, Di Francesco G, Cross C, Bender A, Caldwell J Alzheimers Dement (N Y). 2025; 11(1):e70049.

PMID: 39839075 PMC: 11746070. DOI: 10.1002/trc2.70049.


Recognition memory decline is associated with the progression to prodromal Alzheimer's disease in asymptomatic at-risk individuals.

Raposo Pereira F, Chaumon M, Dubois B, Bakardjian H, Bahrami M, Habert M J Neurol. 2024; 272(1):70.

PMID: 39680203 DOI: 10.1007/s00415-024-12834-y.


Physical activity is associated with lower cerebral beta-amyloid and cognitive function benefits from lifetime experience-a study in exceptional aging.

Treyer V, Meyer R, Buchmann A, Crameri G, Studer S, Saake A PLoS One. 2021; 16(2):e0247225.

PMID: 33606797 PMC: 7895362. DOI: 10.1371/journal.pone.0247225.


Interaction between Cognitive Reserve and Biomarkers in Alzheimer Disease.

Carapelle E, Mundi C, Cassano T, Avolio C Int J Mol Sci. 2020; 21(17).

PMID: 32872643 PMC: 7503751. DOI: 10.3390/ijms21176279.


Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing.

Cunnane S, Trushina E, Morland C, Prigione A, Casadesus G, Andrews Z Nat Rev Drug Discov. 2020; 19(9):609-633.

PMID: 32709961 PMC: 7948516. DOI: 10.1038/s41573-020-0072-x.


References
1.
Sakono M, Zako T . Amyloid oligomers: formation and toxicity of Abeta oligomers. FEBS J. 2010; 277(6):1348-58. DOI: 10.1111/j.1742-4658.2010.07568.x. View

2.
Herholz K, Salmon E, Perani D, Baron J, Holthoff V, Frolich L . Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage. 2002; 17(1):302-16. DOI: 10.1006/nimg.2002.1208. View

3.
Serra L, Cercignani M, Petrosini L, Basile B, Perri R, Fadda L . Neuroanatomical correlates of cognitive reserve in Alzheimer disease. Rejuvenation Res. 2011; 14(2):143-51. DOI: 10.1089/rej.2010.1103. View

4.
Dowling N, Johnson S, Gleason C, Jagust W . The mediational effects of FDG hypometabolism on the association between cerebrospinal fluid biomarkers and neurocognitive function. Neuroimage. 2014; 105:357-68. PMC: 4262609. DOI: 10.1016/j.neuroimage.2014.10.050. View

5.
Stern Y . Cognitive reserve in ageing and Alzheimer's disease. Lancet Neurol. 2012; 11(11):1006-12. PMC: 3507991. DOI: 10.1016/S1474-4422(12)70191-6. View